BioSpace News Archive

Pfizer vaccine head Kathrin Jansen is stepping down from the pharma giant after spearheading the development of the COVID-19 vaccine Comirnaty.

Emergent BioSolutions Founder and former chief executive officer Fuad El-Hibri has died, the company reported.

Therapeutic Solutions International is targeting long COVID with a new stem cell therapy, as Tonix and Pfizer explore their own treatment options.

Gilead and Dragonfly announced their collaboration today, with an end goal of bringing the DF7001 NK engager program designed for patients with cancer or inflammatory diseases.

Hutchmed failed to secure FDA approval for its proposed drug for pancreatic cancer. The company will have to go through another trial if they want U.S. approval.

Albany NY, United States: Osteosynthesis is a surgical procedure with an open or percutaneous approach to the fractured bone.

Nicox SA announced poster presentations highlighting the effect of NCX 4251 in patients with dry eye disease as well as new non-clinical evidence of neuroprotective activity on NCX 470 at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting, one of the key scientific events in vision research, being held in person on May 1-4, 2022 in Denver, CO, United States and virtually on May 11-12.

OSE Immunotherapeutics SA announced the grant of a new patent from the European Patent Office strengthening the protection covering its novel myeloid cell immune checkpoint target, CLEC-1, and its use in cancer treatment.

The global biotechnology & pharmaceutical services outsourcing market is foreseen to demonstrate notable expansion avenues during the assessment period of 2020 to 2030, highlights an upcoming research report by TMRR.

Albany NY, United States: According to the Hearing Loss Association of America, hearing loss is considered to be the third-most common physical condition after arthritis and heart disease, affecting people of all ages.